Non-taking oral antithrombotic agents in patients with ischemic stroke

Clinical Neurology

Volumn 51, Issue 1, 2011, Pages 35-37

  Ito, Yasuyuki ^a   Mitsufuji, Takashi ^a   Yamamoto, Fumio ^a   Hashimoto, Yoichiro ^a   Hirano, Teruyuki ^b   Uchino, Makoto ^b  

^a KUMAMOTO CITY HOSPITAL   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Antithrombotic agents; Continuing medication; Ischemic stroke; Outreach; Secondary prevention

Indexed keywords

ANTICOAGULANT AGENT;

AGED; ARTICLE; ATHEROTHROMBOTIC INFARCTION; BRAIN ISCHEMIA; CARDIAC PATIENT; CARDIOEMBOLISM; FEMALE; HEART INFARCTION; HUMAN; LACUNAR INFARCTION; MAJOR CLINICAL STUDY; MALE; RECURRENT DISEASE; STROKE; TRANSIENT ISCHEMIC ATTACK;

EID: 79551594161     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: 10.5692/clinicalneurol.51.35     Document Type: Article

References (10)

1. Hata J, Tanizaki Y, Kiyohara Y, et al. Ten year recurrence after first ever stroke in a Japanese community: the Hisayama study. J Neurol Neurosurg Psychiatry 2005;76:368-372. (Pubitemid 40299127)
2. Gotoh F, Tohgi H, Hirai S, et al. Cilostazol stroke prevention study: a placebo-controlled double-blind trial for secondary prevention of cerebral infarction. J Stroke Cerebrovasc Dis 2000;9:147-157.
3. Hamann GF, Weimar G, Glahn J, et al. Adherence to secondary stroke prevention strategies - results from the German Stroke Data Bank. Cerebrovasc Dis 2003;15:282-288.
4. Gencheva E, Sloan M, Leurgans S, et al. Attrition and non-compliance in secondary stroke prevention trials. Neuroepidemiology 2004;23:61-66.
5. Cheng EM, Cohen SN, Lee ML, et al. Use of antithrombotic agents among U.S. stroke survivors, 2000-2006. Am J Prev Med 2010;38:47-53.
6. Glader EL, Sjölander M, Eriksson M, et al. Persistent use of secondary preventive drugs declines rapidly during the first 2 years after stroke. Stroke 2010;41:397-401.
7. Feinberg WM, Albers GW, Barnett HJM, et al. Guidelines for the management of transient ischemic attacks. From the Ad Hoc Committee on guidelines for the management of transient ischemic attacks of the Stroke Council of the American Heart Association. Stroke 1994;25:1320-1335.
8. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.
9. EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993;342:1255-1262.
10. Kalra L, Perez I, Smithard DG, et al. Does prior use of aspirin affect outcome in ischemic stroke? Am J Med 2000; 108:205-209.